LONG TERM SAFETY AND EFFICACY OF CAR-T CELL TREATMENT IN REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS - DATA FROM THE FIRST SEVEN PATIENTS

被引：8

作者：

Taubmann, J. ^{[1
,2
,3
,4
]}

Mueller, F. ^{[2
,3
,4
,5
]}

Boeltz, S. ^{[1
,2
,3
,4
]}

Voelkl, S. ^{[2
,3
,4
,5
]}

Aigner, M. ^{[2
,3
,4
,5
]}

Kleyer, A. ^{[1
,2
,3
,4
]}

Minnopoulou, I. ^{[1
,2
,3
,4
]}

Locatelli, F. ^{[6
]}

D'agostino, M. A. ^{[7
]}

Gary, R. ^{[2
,3
,4
,5
]}

Krestchmann, S. ^{[2
,3
,4
,5
]}

Kharboutli, S. ^{[2
,3
,4
,5
]}

Mougiakakos, D. ^{[2
,3
,4
,5
,8
]}

Kroenke, G. ^{[1
,2
,3
,4
]}

Andreas, M. ^{[2
,3
,4
,5
]}

Schett, G. ^{[1
,2
,3
,4
]}

机构：

[1] Univ Klinikum Erlangen Nurnberg, Dept Internal Med 3 Rheumatol & Immunol, Erlangen, Germany

[2] Friedrich Alexander Univ Erlangen Nurnberg, Erlangen, Germany

[3] Friedrich Alexander Univ Erlangen Nuremberg, Deutsch Zentrum Immuntherapie DZI, Erlangen, Germany

[4] Univ Klinikum Erlangen, Erlangen, Germany

[5] Univ Klinikum Erlangen Nurnberg, Dept Internal Med 5 Hematol & Oncol, Erlangen, Germany

[6] Osped Pediat Bambino Gesu, Dept Pediat Onco Hematol & Transfus Med, Bambino Gesu, Rome, Italy

[7] Catholica Univ, Div Rheumatol, Fdn Policlin Univ A Gemelli, Sacred Heart, Rome, Italy

[8] Univ Klin Hamatol & Onkol, Hamatol & Onkol, Univ Klinikum Magdeburg AoR, Magdeburg, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

Systemic lupus erythematosus; Remission; Treat to target;

D O I：

10.1136/annrheumdis-2023-eular.3736

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OP0141

引用

页码：93 / 94

页数：2

共 50 条

[41] Treatment of two pediatric patients with refractory systemic lupus erythematosus using CD19-targeted CAR T-cells
He, Xue
Hu, Bin
Zhang, Yingzi
Liu, Fei
Li, Qiuyu
Zheng, Chen
Shen, Junjie
Yang, Zhi
Wang, Jingjing
Ma, Daqing
Qian, Cheng
Lu, Meiping
Mao, Jianhua
AUTOIMMUNITY REVIEWS, 2025, 24 (01)
[42] Safety and Efficacy of CD19 CAR-T Cells for Refractory Systemic Sclerosis: A Phase I Clinical Trial
Feng, Jingjing
Hu, Yongxian
Zhang, Mingming
Cao, Heng
Ke, Yini
Xu, Huijun
Cui, Jiazhen
Zhang, Yanlei
Chang, Alex Hongsheng
Lin, Jin
Wei, Guoqing
Huang, He
BLOOD, 2022, 140 : 10335 - 10336
[43] Possible Factors on Efficacy and Safety of CAR-T Therapy in Relapsed or Refractory Aggressive B-Cell Lymphoma
Huang, Haiwen
Jiang, Yibin
Jin, Zhengming
Li, Caixia
Wu, Depei
BLOOD, 2018, 132
[44] Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma
Jin, Chunxiang
Chen, Rongrong
Fu, Shan
Zhang, Mingming
Teng, Yuanyin
Yang, Tingting
Song, Fengmei
Feng, Jingjing
Hong, Ruimin
Cui, Jiazhen
Huang, Simao
Xu, Huijun
Zhang, Yanlei
Wei, Guoqing
Cai, Zhen
Kwong, Yok-Lam
Chan, Thomas Sau Yan
Chang, Alex H.
Huang, He
Hu, Yongxian
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
[45] Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network
Rudzki, Jakob D.
Jaeger, Ulrich
Wolf, Dominik
Petzer, Andreas
Greil, Richard
Peters, Christina
Greinix, Hildegard T.
Attarbaschi, Andishe
Buxhofer-Ausch, Veronika
Girschikofsky, Michael
Holter, Wolfgang
Leisch, Michael
Neumeister, Peter
Schlenke, Peter
Schmitt, Clemens A.
Schwinger, Wolfgang
Worel, Nina
Wohlfarth, Philipp
BLOOD, 2022, 140 : 6661 - 6663
[46] B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis
Tian, Dai-Shi
Qin, Chuan
Dong, Ming-Hao
Heming, Michael
Zhou, Luo-Qi
Wang, Wen
Cai, Song-Bai
You, Yun-Fan
Shang, Ke
Xiao, Jun
Wang, Di
Li, Chun-Rui
Zhang, Min
Bu, Bi-Tao
Meyer zu Hoerste, Gerd
Wang, Wei
EMBO MOLECULAR MEDICINE, 2024, 16 (04) : 966 - 987
[47] New insights in systemic lupus erythematosus: From regulatory T cells to CAR-T-cell strategies
Doglio, Matteo
Alexander, Tobias
Del Papa, Nicoletta
Snowden, John A.
Greco, Raffaella
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 150 (06) : 1289 - 1301
[48] Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
McCarthy, Eoghan M.
Sutton, Emily
Nesbit, Stephanie
White, James
Parker, Ben
Jayne, David
Griffiths, Bridget
Isenberg, David A.
Rahman, Anisur
Gordon, Caroline
D'Cruz, David P.
Rhodes, Benjamin
Lanyon, Peter
Vital, Edward M.
Yee, Chee-Seng
Edwards, Christopher J.
Teh, Lee-Suan
Akil, Mohammed
McHugh, Neil J.
Zoma, Asad
Bruce, Ian N.
RHEUMATOLOGY, 2018, 57 (03) : 470 - 479
[49] Long-term efficacy and tolerability of levetiracetam treatment in a patient with epilepsy affected by systemic lupus erythematosus
Siniscalchi, A.
Mancuso, F.
Gallelli, L.
De Sarro, G.
EPILEPSIA, 2006, 47 : 46 - 47
[50] Safety and Preliminary Efficacy of CD19 CAR-T Cell Treatment in Rheumatic Disease - Data from the First Part of the Phase I/II CASTLE Basket Study
Schett, Georg
Mueller, Fabian
Hagen, Melanie
Wirsching, Andreas
Bohr, Daniela
Bergmann, Christina
Tur, Carlo
Voelkl, Simon
Aigner, Michael
Kretschmann, Sascha
Spoerl, Silvia
Kharboutli, Soraya
Vasova, Ingrid
Aletaha, Daniel
Kiener, Hans
Natalello, Gerlando
Locatelli, Franco
D'Agostino, Maria Antonietta
Bozec, Aline
Grieshaber-Bouyer, Ricardo
MAckensen, Andreas
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3573 - 3574

← 1 2 3 4 5 →